Sarcopenia’s impact on early-onset colorectal cancer
Part of Brain & nervous system, Cancer, Digestive system clinical trials.
This study looks at how muscle loss (sarcopenia) affects people diagnosed with colorectal cancer before age 50. It uses CT or MRI scans taken at diagnosis to measure muscle mass and see how it relates to treatment and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 49 years old.
- You have been diagnosed with colorectal cancer before age 50.
- You went to the emergency room for a suspected surgery-related problem.
- You had a CT or MRI scan taken at the time of diagnosis that can be reviewed for muscle mass.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether low muscle mass (sarcopenia) before surgery affects recovery for older adults with gastrointestinal cancer. It may help doctors personalize care and improve outcomes.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.
This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.
This study checks for muscle loss (sarcopenia) in people aged 65 or older who are waiting for hip replacement surgery. It aims to see how common muscle loss is and may help improve care before and after surgery.
This study compares patients diagnosed with colorectal cancer at a younger age (under 50) to those diagnosed later in life. By looking at tissue samples and patient surveys, researchers hope to understand differences in the disease and improve care for all ages.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.